According to Zhitong Finance App, Shiyao Group (01093) announced that the company's subsidiary, Shiyao Innovative Pharmaceutical Co., Ltd. (CSPC Innovation), achieved operating revenue of 3,976 billion yuan in the first three quarters of 2026, an increase of 149.62% over the previous year; net profit attributable to shareholders of listed companies of 1.21 billion yuan; and basic earnings per share of 0.8688 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.